A Specific Inhibitor of Complement (C5)-Derived Chemotactic Activity in Serum from Patients with Systemic Lupus Erythematosus

In the course of examining polymorphonuclear leukocyte (PMN) chemotaxis in patients with systemic lupus erythematosus (SLE), we have found a previously undescribed serum inhibitor of complement (C5)-derived chemotactic activity. Serum from a 25-yr-old Black female with untreated SLE, when activated...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Perez, H. Daniel, Lipton, Mark, Goldstein, Ira M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1978
Assuntos:	Articles
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371733/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/659635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109110
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!